Company / Shares Outstanding
Inhibrx Biosciences, Inc. Shares Outstanding History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
14.5M
FY2025
5-year range
11.8M / 47.4M
FY2023-FY2025
Trend
-69.4%
vs FY2024
Sector context
#204 of 212
Health Care
What the data says
Among 212 Health Care companies, Inhibrx Biosciences, Inc. is in the top 4% for shares outstanding. Increased from 11783000.00 to 14475904.00 over the past 2 years.
Based on SEC 10-K filings.
14475904.00 in FY2025.
Increased from 11783000.00 to 14475904.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 212This company 14.5M Sector average 306.7M
▼
-95.3% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding decreased 69.4% year-over-year.
- Ranks #204 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.5M | -69.4% |
| FY2024 | 47.4M | +302.0% |
| FY2023 | 11.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026